Bill > S2537

This bill establishes minimum standards for insulin patient assistance programs (PAPs) offered by manufacturers of insulin products. Key provisions include: - Requiring manufacturers to provide a one-time, 30-day supply of insulin at no cost to individuals who urgently need it and attest to financial need. - Mandating that manufacturers make insulin PAP application forms freely available, process applications in a reasonable timeframe, and enroll eligible individuals for 12-month terms. - Defining eligibility criteria for insulin PAPs, including income limits, lack of private prescription drug coverage, and exclusion from other government-sponsored drug programs (except Medicare Part D). - Imposing a $10,000 per month administrative penalty on manufacturers who fail to comply with the law, with an appeals process. - Designating the Department of Public Health to enforce the law. The bill aims to improve access to affordable insulin for low-income and uninsured individuals by establishing consistent standards for manufacturer-provided patient assistance programs.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/192/S2537